Tony Dunk - St Jude Director - Investor Relations
Director
Tony Dunk is Director - Investor Relations of St Jude Medical
| Phone | 651 756-3301 |
| Web | www.sjm.com |
St Jude Management Efficiency
St Jude's management efficiency ratios could be used to measure how well St Jude manages its routine affairs as well as how well it operates its assets and liabilities.The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. St Jude Medical has a current ratio of 1.89, which is typical for the industry and considered as normal. Debt can assist St Jude until it has trouble settling it off, either with new capital or with free cash flow. So, St Jude's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like St Jude Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for STJ to invest in growth at high rates of return. When we think about St Jude's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Lynton | Pearson PLC ADR | 61 | |
| Thomas Reddin | Deluxe | 60 | |
| Lisa Hook | Relx PLC ADR | 57 | |
| Lincoln Wallen | Pearson PLC ADR | 60 | |
| Charles Haggerty | Deluxe | 73 | |
| Michal Votruba | MYnd Analytics | 52 | |
| Ian Fraser | Relx PLC ADR | N/A | |
| Donald McGrath | Deluxe | 72 | |
| Vijay Raghavan | Relx PLC ADR | N/A | |
| Andrew Sassine | MYnd Analytics | 51 | |
| Elizabeth Corley | Pearson PLC ADR | 63 | |
| Ben Veer | Relx PLC ADR | 67 | |
| Nick Luff | Relx PLC ADR | 49 | |
| Suzanne Wood | Relx PLC ADR | 60 | |
| Sally Johnson | Pearson PLC ADR | 51 | |
| Robert Polet | Relx PLC ADR | 59 | |
| Nicholas Luff | Relx PLC ADR | 57 | |
| John Pappajohn | MYnd Analytics | 89 | |
| Coram Williams | Pearson PLC ADR | 44 | |
| Linda Sanford | Relx PLC ADR | 68 | |
| Marike Lels | Relx PLC ADR | 61 | |
Management Performance
| Return On Equity | 0.23 | |||
| Return On Asset | 0.0011 |
St Jude Medical Leadership Team
Elected by the shareholders, the St Jude's board of directors comprises two types of representatives: St Jude inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STJ. The board's role is to monitor St Jude's management team and ensure that shareholders' interests are well served. St Jude's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, St Jude's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Lamb, Managing Director, Executive Director | ||
| Baroness Wheatcroft, Non-Executive Independent Director | ||
| Ian Gascoigne, Managing Director, Executive Director | ||
| John Heinmiller, Executive VP | ||
| Tony Dunk, Director - Investor Relations | ||
| Denis Gestin, President of International Division | ||
| Craig Gentle, CFO | ||
| Stephan Widensohler, Independent Director | ||
| Donald Zurbay, CFO and VP of Fin. | ||
| Lisa Andrade, Chief Marketing Officer | ||
| Wendy Yarno, Independent Director | ||
| Iain Cornish, Senior Independent Non-Executive Director | ||
| Richard Devenuti, Independent Director | ||
| Sarah Bates, Non-Executive Chairman of the Board | ||
| Jeffrey Dallager, Vice President Corporate Controller | ||
| Joel Becker, President - Americas Division | ||
| Stuart Essig, Independent Director | ||
| Andrew Croft, CFO, Executive Director | ||
| Barbara Hill, Independent Director | ||
| David Bellamy, Chief Executive, Executive Director | ||
| Roger Yates, Independent Non-Executive Director | ||
| John Brown, Independent Presiding Director | ||
| Daniel Starks, Executive Chairman | ||
| Eric Fain, Group President - St. Jude Medical | ||
| Elizabeth Kelly, Company Secretary | ||
| Rachel Ellingson, Vice President - Corporate Relations | ||
| Mark Carlson, Vice President - Global Clinical Affairs, Chief Medical Officer | ||
| Paul Bae, Chief Marketing Officer, Vice President - Global Human Resources | ||
| Michael Rousseau, CEO and President COO and Director | ||
| Mark Murphy, CIO and VP of Information Technology | ||
| Scott Thome, Vice President - Global Operations and Supply Chain | ||
| Michael Rocca, Independent Director | ||
| Simon Jeffreys, Independent Non-Executive Director | ||
| Jeff Fecho, Vice President - Global Quality | ||
| Jason Zellers, Vice President General Counsel, Corporate Secretary | ||
| J Weigelt, Director - Investor Relations | ||
| David Dvorak, Director | ||
| Robert Gardner, Director of Investment Management | ||
| Stefan Widensohler, Independent Director |
STJ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is St Jude a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | |||
| Return On Asset | 0.0011 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 21.11 % | |||
| Current Valuation | 19.98 B | |||
| Shares Outstanding | 282.2 M | |||
| Shares Owned By Insiders | 2.44 % | |||
| Shares Owned By Institutions | 86.30 % | |||
| Number Of Shares Shorted | 8.18 M | |||
| Price To Earning | 35.37 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in STJ Stock
If you are still planning to invest in St Jude Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the St Jude's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |